ZBH Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
2.2B
+4.3%
2.1B
-7.0%
2.2B
+12.1%
2.0B
-3.7%
2.1B
Cost of Revenue
635.5M
+10.3%
576.2M
-27.3%
792.4M
+41.7%
559.3M
-5.6%
592.2M
Gross Profit
1.5B
+2.1%
1.5B
+4.1%
1.5B
+0.6%
1.4B
-2.9%
1.5B
Operating Expenses
1.2B
+6.9%
1.1B
-12.3%
1.3B
+18.9%
1.1B
-8.0%
1.2B
R&D
104.8M
+1.4%
103.4M
-12.9%
118.7M
+2.4%
115.9M
+2.3%
113.3M
SG&A
899.3M
+5.8%
849.9M
-2.6%
872.3M
+7.5%
811.4M
-0.4%
814.8M
Operating Income
326.1M
-12.6%
373.2M
+141.6%
154.5M
-56.0%
351.3M
+17.1%
300.0M
EBITDA
626.7M
-3.5%
649.5M
+19.2%
544.8M
-17.0%
656.3M
+11.4%
589.3M
Net Income
199.6M
-16.3%
238.4M
+72.9%
137.9M
-40.4%
231.2M
+50.7%
153.4M
EPS (Basic)
$1.03
-15.6%
$1.22
+71.8%
$0.71
-39.3%
$1.17
+51.9%
$0.77
EPS (Diluted)
$1.03
-15.6%
$1.22
+74.3%
$0.70
-39.7%
$1.16
+50.6%
$0.77
Shares (Diluted)
192.8M
-1.5%
195.8M
-1.1%
198.0M
-0.4%
198.8M
+0.3%
198.3M
Zimmer Biomet (ZBH) โ€” Financials